Research focuses on population-aware genomics, bioinformatics, and pharmacogenetics, integrating statistical genetics, transcriptomics, epigenomics, and functional genomics to improve disease-risk prediction, drug-response assessment, and equitable precision medicine across ancestrally diverse populations.